Pfizer-BioNTech mRNA Vaccine Protection among Children and Adolescents Aged 12–17 Years against COVID-19 Infection in Qatar

Pfizer-BioNTech mRNA Vaccine Protection among Children and Adolescents Aged 12–17 Years against COVID-19 Infection in Qatar

Qatar was also hit hard by the global pandemic of SARS-CoV-2, with the original virus, Alpha variant, Beta variant, Omicron BA.1 and BA.2 variants, Omicron BA.4 and BA.5 variants, and Delta variant, sequentially. The two-dose primary series of BNT162b2 (Pfizer-BioNTech) COVID-19 vaccine against SARS...

Full description

Bibliographic Details
Main Authors: Khadieja Osman, Jesha Mundodan, Juel Chowdhury, Rejoice Ravi, Rekayahouda Baaboura, Jeevan Albuquerque, Bilal Riaz, Reem Yusuf Emran, Khatija Batoul, Abdul Mahmood Esameldin, Zinah Al Tabatabaee, Hayat Khogali, Soha Albayat
Format: Article
Language:English
Published: MDPI AG 2023-09-01
Series:Vaccines
Subjects:
adolescent
children
12–17 years COVID-19 vaccine
fully vaccinated
partially vaccinated
vaccination status
Online Access:https://www.mdpi.com/2076-393X/11/10/1522

Internet

https://www.mdpi.com/2076-393X/11/10/1522

Similar Items